Drug Type Synthetic peptide vaccine, Therapeutic vaccine |
Synonyms hTERT-derived peptide vaccine, Human telomerase reverse transcriptase peptide-based vaccine, UCP2-UCP4 vaccine + [1] |
Target |
Action modulators |
Mechanism TERT modulators(Telomerase reverse transcriptase modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Unresectable Hepatocellular Carcinoma | Phase 2 | France | 27 Sep 2022 | |
Non-Small Cell Lung Cancer | Phase 2 | France | 03 Oct 2020 | |
Glioblastoma Multiforme | Phase 2 | France | 26 May 2020 | |
Glioblastoma, IDH-Wildtype | Phase 2 | France | 26 May 2020 | |
Anal Canal Carcinoma | Phase 2 | France | 18 Feb 2020 | |
HPV-related carcinoma | Phase 2 | France | 18 Feb 2020 | |
Squamous Cell Carcinoma of Head and Neck | Phase 2 | France | 18 Feb 2020 | |
Uterine Cervical Cancer | Phase 2 | France | 18 Feb 2020 | |
Advanced Lung Non-Small Cell Carcinoma | Phase 2 | - | 23 Jan 2020 | |
metastatic non-small cell lung cancer | Phase 2 | France | 20 Apr 2016 |
Phase 2 | - | buisoqzwbt(gxipyafxft) = jxbcxjtmjk temhivjkyf (giasskaocu ) View more | Positive | 30 May 2025 | |||
Phase 2 | Neoplasms HPV-related ctDNA | 44 | irzkmvpief(wadclelsoq) = ucadwcljht gqukweaxio (qzskeowakm ) View more | Positive | 14 Sep 2024 | ||
(HPV-related ctDNA detectable at baseline) | akznggqcke(uhbvdwibxp) = rztqzxbkbk iextwpzmil (ejqojawskp ) | ||||||
Not Applicable | - | UCPvax Vaccine | rhfcstztdc(jlsivqxmpc) = 13 patients experienced local pain (≤grade 2) bvfutbssnj (rjgmrexrul ) View more | - | 08 Sep 2023 | ||
Phase 2 | Glioblastoma First line | 31 | ucpbvzvzca(ykvwnjaalu) = vvkcsbkwyc jiuxecszzt (tzimwsgupu ) View more | Positive | 26 May 2023 |